Ronald Mann, Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing ...

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

We’re officially just days away from the 2026 NFL draft, meaning it’s time to get those final thoughts and projections in after months of preparation. MLive’s Dungeon of Doom podcast opened the ...

The Philadelphia Eagles shattered record-breaking viewership numbers in Sundayâ s devastating loss. As NBC Sports noted, Sundayâ s Eagles-49ers matchup averaged 41 million viewers, making it the most ...

The weather will not be a factor this week for the 90th edition of the Masters at Augusta National Golf Club. With the course expected to play firm and fast, there are a number of top players in the ...

The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...

The Nashville Predators currently hold the second wild card spot in the Western Conference playoff race. Following a three-game losing streak, the team's playoff chances have dropped to 21.3%. Several ...

Former world No.1 Yevgeny Kafelnikov has urged tournament organizers to stop granting wildcards to Venus Williams following her first-round exit at Indian Wells. Williams, currently ranked world ...

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...

Venus Williams is heading back to the Southern California desert. The BNP Paribas Open unveiled announced on Friday that the former world No. 1 has received the first main draw wild card for both ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...